APP and Alzheimer disease: ELAV-like RNA binding protein 4 (ELAVL4) has been found to interact with other transcripts linked to AD, such as APP and β-site APP-cleaving enzyme 1 (BACE1), and to increase the half-lives of these mRNAs (Kang et al., 2014).